Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Grabar Law Office is actively investigating potential breaches of fiduciary duty by Ocugen, Inc. (NASDAQ: OCGN) officers and directors. This investigation could lead to significant financial recovery opportunities for long-term shareholders.
Why This Matters:
On April 1, 2024, Ocugen filed a Notification of Late Filing with the SEC, revealing accounting errors related to collaboration agreements. These errors led to a restatement of financial statements for 2022 and 2023, calling into question the integrity of Ocugen's financial reporting and internal controls.
A securities fraud class action complaint has been filed, alleging that Ocugen misrepresented its financial stability and failed to disclose inadequate internal controls, misleading investors about the company's business and prospects. This could have serious financial repercussions for shareholders who trusted in the company's reported performance.
Who Can Take Action:
If you have held Ocugen shares since before May 8, 2020, you have the right to:
- Seek corporate reforms to safeguard the company from future misconduct.
- Demand the return of funds spent defending litigation back to Ocugen.
- Pursue a court-approved incentive award, with no out-of-pocket cost.
What to Do Next:
Don't miss this opportunity to protect your investment and hold Ocugen accountable. Visit https://grabarlaw.com/the-latest/ocugen-shareholder-investigation/ for more details. You can also contact Joshua H. Grabar directly at jgrabar@grabarlaw.com or call 267-507-6085.
Attorney Advertising Disclaimer
#Ocugen #OcugenInvestigation #ShareholderRights #FiduciaryDuties #CorporateAccountability #InvestorAlert #GrabarLawOffice $OCGN
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228571
